Search Results for: PULMONARY DELIVERY Pulmonary Delivery of
Articles
November 8, 2012
11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
September 3, 2012
9/5/2012 September 3, 2012
Genmab Signs Potential Billion Dollar Agreement Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human...
September 3, 2012
Sunovion to Buy Company in Deal Worth $430 Million September 3, 2012
Sunovion Pharmaceuticals Inc. recently announced it has signed a definitive agreement to acquire Elevation Pharmaceuticals, Inc. The acquisition includes Elevation...
August 12, 2012
8/15/2012 August 12, 2012
Quintiles Acquires Company to Advance Personalized Medicine Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider...
August 5, 2012
8/8/2012 August 5, 2012
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence...
August 5, 2012
Aptar's Dose Indicator Chosen for Allergic Rhinitis August 5, 2012
ZETONNA (ciclesonide) Nasal Aerosol from Sunovion Pharmaceuticals Inc., equipped with an Aptar Pharma Landmark® dose indicator, is now available in...
June 25, 2012
6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...
June 25, 2012
MicroDose Therapeutx & Moerae Matrix Announce Collaboration June 25, 2012
MicroDose Therapeutx, Inc. and Moerae Matrix, Inc. recently announced they have signed a collaboration agreement to develop a dry powder...
May 6, 2012
5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
April 8, 2012
4/10/2012 April 8, 2012
Catalent & BASF Join Forces to Solve Bioavailabilty Challenges Catalent Pharma Solutions and BASF recently announced they have entered into...
March 21, 2012
3/27/2012 March 21, 2012
Marinomed's Nasal Spray Achieves Positive Clinical Results Marinomed Biotechnologie GmbH, recently announced that data from a clinical trial for the...
February 29, 2012
3/6/2012 February 29, 2012
Avanir & Concert Announce Exclusive License Agreement Avanir Pharmaceuticals, Inc. and Concert Pharmaceuticals, Inc. recently announced they have entered into...
February 16, 2012
2/21/2012 February 16, 2012
Catalent Pharma Solutions & NewMarket Sign Development Agreement Catalent Pharma Solutions and NewMarket Pharmaceuticals LLC recently announced they have entered...
February 16, 2012
IntelGenx Announces License Agreement With Edgemont Pharmaceuticals February 16, 2012
IntelGenx Corp. recently announced it has entered into an exclusive agreement with Edgemont Pharmaceuticals, LLC for the commercialization of IntelGenx's...
December 18, 2011
12/20/2011 December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and...
December 18, 2011
Pulmatrix Presents iSPERSE Data for Inhaled Combination Therapies December 18, 2011
Pulmatrix recently announced that its iSPERSE inhaled drug platform demonstrated multi-drug delivery capability and superiority over conventional lactose blending for...
December 11, 2011
12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...
September 27, 2011
10/4/2011 September 27, 2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking...
May 5, 2011
5/10/2011 May 5, 2011
QRxPharma Completes Patient Enrolment of Phase III Comparative Safety Study QRxPharma Limited recently announced it has completed patient enrolment for...
May 5, 2011